Abstract:Objective To explore the effects of dialysate calcium concentrations (DCC)on risks of adverse reactions occurred in maintenance hemodialysis patients during dialysis. Methods The subjects were end-stage renal disease (ESRD)patients in stable condition who were treated with maintenance dialysis in the First Affiliated Hospital,Zhejiang University from June to October 2016. According to the DCC,the patients were randomly divided into 3 groups,the 1.25 mmol/L group,the 1.35 mmol/L group,and the 1.50 mmol/L group;the observation time was 12 weeks. The urea clearance index Kt/V,urea reduction rate (URR),mean arterial pressure before and after dialysis,the serum calcium,serum phosphorus,intact parathyroid hormone (iPTH),and alkaline phosphatase (ALP)levels before and after dialysis,and the incidence of muscle spasm,nausea and vomiting,headache,chest tightness,and arrhythmia in hemodialysis patients in the 3 groups were compared. Results A total of 273 patients entered the study,including 159 males and 114 females with ages from 25 to 83 years and average age of (52 ± 9)years. Each of the 1.25 mmol/L,1.35 mmol/L,and 1. 50 mmol/L groups comprised 91 patients. The differences of baseline data in patients in the 3 groups were not statistically significant (P＞0.05). After 12 weeks of hemodialysis,the differences of Kt/V and URR in patients in the 3 groups were not statistically significant (all P＞0.05);the differences of the mean arterial pressures in patients in the 1.25 and 1.35 mmol/L groups [(102 ± 9)and (103 ±11)mmHg,respectively]were not statistically significant (all P ＞0.0.5);the mean arterial pressure in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(120 ± 12) mmHg vs.(103 ± 9)mmHg,P＜0.01]and was higher markedly than that in 1.25 and 1.35 mmol/L groups (all P＜0.01);the serum calcium level in patients in the 1.25 mmol/L group was lower than that before hemodialysis [(1.94 ± 0.31)mmol/L vs.(2.24 ± 0.18)mmol/L,P＜0.01];the serum calcium level in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(2.54 ± 0.18) mmol/L vs.(2.24 ± 0.17)mmol/L,P＜0.01];the iPTH and ALP levels in patients in the 1.25 mmol/L group were higher than those before hemodialysis [(356 ± 68)U vs.(291 ± 49)U,(443 ± 45)U vs. (343 ± 58)U,all P ＜0.01]. During dialysis,the incidence of muscle spasm in patients in the 1.25 mmol/L group was higher than that in the 1.35 mmol/L and 1.50 mmol/L groups [14.28% (13/91)vs. 5.49% (5/91)and 4.39% (4/91),all P ＜0.05];the incidence of headache in patients in the 1.50 mmol/L group was higher than that in the 1.25 mmol/L and 1.35 mmol/L groups [14.28% (13/91)vs. 3.30% (3/91)and 5.49% (5/91),P ＝0.01 and P ＜0.05]. The differences in incidences of chest tightness,arrhythmia,nausea and vomiting were not statistically significant (all P＞0.05). Conclusion The dialysate with calcium concentration of 1.35 mmol/L may reduce the incidence of muscle spasm,does not increase the incidence of hypertension and headache,and effectively reduce the risk of adverse reactions in maintenance hemodialysis patients,while ensuring the adequacy of dialysis.

Influence of compound α-keto acid tablets on micro-inflammation status patients udnergoing maintenance hemodialysis

Effect of lipoic acid on oxidative stress, inflammation and nutritional status in peritoneal dialysis patients

The Effects of Oral Vitamin Con Microinflammatory State in Hemodialysis Patients

Upgrade of dialysate quality improves the microinflammation in maintenance haemodialysis patients

A Clinical study on the Effect of Peritoneal Dialysis and Hemodialysis on the Microinflammatory State and Quality of Life in Patients with Chronic Renal Failure

Cross-over Study of Influence of Oral Vitamin C Supplementation on Inflammatory Status in Maintenance Hemodialysis Patients.

Microinflammation associated with dyslipidemia and nutritional status in maintenance hemodialysis patients

Randomized Controlled Trial of Dialysate Calcium Concentrations on Risks of Adverse Reactions in Hemodialysis Patients During Dialysis

Association of Serum L-kynurenine with Nutritional Status and Vascular Stiffness in Maintenance Hemodialysis Patients

Effect of peritoneal dialysis on inflammatory factors,nutritional index and renal function in patients with chronic renal failure

Effect of intradialytic physical exercise on toxin removal and inflammatory status in maintenance hemodialysis patients

Effects of Microbiological Improvement of Dialysate on Nutritional Status and Inflammatory Parameters in Maintenance Hemodialysis Patients

High-flux Hemodialysis Efficiently Removes Β_2-Microglobin and Improves Inflammation Status in Maintain Hemodialysis Patients

Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways

Efficacy and Safety of Compound Amino Acid Capsules in the Treatment of Malnutrition and Calcium and Phosphorus Metabolism Disorders in Maintenance Hemodialysis Patients

Effect of hemodialysis combined with blood perfusion and comprehensive nursing intervention on the levels of interleukin-6, C-reactive protein and β2-microglobulin in patients with diabetic nephropathy

Serum Level of Hydrogen Sulfide and Its Influential Factors in Patients Undergoing Maintenance Hemodialysis

Aspirin Can Reduce Serum C Reactive Protein Level in Maintenance Hemodialysis Patients

Impact of -ketoacids on the quality of life in end-stage renal disease patients on maintenance dialysis

Effect of periodontal non-surgical treatment on systemic and local inflammation in patients with maintenance hemodialysis

Serum hepcidin is associated with iron status and micro-inflammation in hemodialysis patients